Core competencies
Profile
- Nationality
- Jordanian
- Summary
- Dr. Ayman El-Hattab has the American Board in Pediatrics, the American Board of Clinical Genetics, and the American Board of Biochemical Genetics (Metabolic); he is also a fellow member of the American Academy of Pediatrics (AAP) and the American College of Medical Genetics (ACMG).
Dr. Ayman El-Hattab has more than 15 years of experience in the field of genetics. He has worked at Baylor College of Medicine and University of Missouri in USA, King Fahad Medical City in Saudi Arabia, and he has been working in several hospitals in United Arab Emirates.
Dr. Ayman El-Hattab sees children and adults with confirmed or suspected genetic diseases including children with developmental delay, cognitive impairment, autism, congenital anomalies, growth failure, metabolic diseases and chromosomal and genetic syndromes. He also sees people with variable genetic diseases including cardiac (e.g. cardiomyopathies and arrhythmias), neurologic (e.g. muscle dystrophies and neuropathies), endocrine (e.g. growth hormone deficiency and monogenic diabetes), renal (e.g. malformation and congenital nephrotic syndromes), dermatology (e.g. ichthyosis and epidermolysis bullosa), eye (e.g. retinitis pigmentosa and optic atrophy), and inherited hearing impairment. In addition, people with personal or family history of cancer are seen to be evaluated for inherited cancer syndrome. Genetic screening for inherited diseases is also performed for couples planning to have children.
Dr. Ayman El-Hattab is a Professor at the College of Medicine, University of Sharjah and he is heavily involved in research. He has conducted many clinical research projects, and he has more than 120 publications, several book chapters, and many presentations in scientific conferences. His research fields include chromosomal abnormalities, metabolic disorders, neurogenetic diseases, novel gene and syndrome discovery, and mitochondrial diseases. Professor Ayman El-Hattab has received several awards, and he was designated as one of the world’s top 2% scientists in the field of genetics by Stanford University, USA in a report published in October 2020.
Qualification
- American Board of Clinical Genetics
Practices at
-
Mediclinic City Hospital
Consultant Clinical Genetics
In department Precision Medicine Department